- Home
- Editorial
- News
- Practice Guidelines
- Anesthesiology Guidelines
- Cancer Guidelines
- Cardiac Sciences Guidelines
- Critical Care Guidelines
- Dentistry Guidelines
- Dermatology Guidelines
- Diabetes and Endo Guidelines
- Diagnostics Guidelines
- ENT Guidelines
- Featured Practice Guidelines
- Gastroenterology Guidelines
- Geriatrics Guidelines
- Medicine Guidelines
- Nephrology Guidelines
- Neurosciences Guidelines
- Obs and Gynae Guidelines
- Ophthalmology Guidelines
- Orthopaedics Guidelines
- Paediatrics Guidelines
- Psychiatry Guidelines
- Pulmonology Guidelines
- Radiology Guidelines
- Surgery Guidelines
- Urology Guidelines
A case of Delayed pressure urticaria due to BP Cuff
Siddharth Pandey, Department of Urology, King George’s Medical University, Lucknow, Uttar Pradesh, India, and colleagues report the case of delayed pressure urticaria (DPU) due to BP Cuff application.
According to history, a 68-year-old man presented with voiding lower urinary tract symptoms due to benign prostatic hyperplasia for which he underwent photo vaporization of the prostate using potassium titanyl phosphate laser. The procedure was completed in 104 min uneventfully.
Eight hours after the procedure, the patient had burning and itching on his left arm circumferentially in the area where the cuff for non-invasive blood pressure (NIBP) monitoring was applied and on his back.
Courtesy: BMJ Case Reports
The cuff was removed and in that region of his arm, there was erythema along with multiple blisters. A similar linear lesion was seen on the right side of his back along the 10th rib. It was recognized it to be some form of urticaria, and immediately gave the patient an antihistamine (pheniramine). The patient had no history of any skin lesion, neither did he give a history of any allergies.
Both lesions appeared in areas where there was continuous pressure applied: in the arm by the blood pressure monitoring cuff and on the back while positioning on the operation theatre table against his rib.
A diagnosis of delayed pressure urticaria (DPU) was made, and the patient was given levocetrizine (5 mg) plus montelukast (10 mg) once daily along with oral prednisolone after which the lesions gradually subsided.
Delayed pressure urticaria is usually seen in patients with a previous history of urticaria or angioedema, but the diagnosis may be missed if specific history regarding weals developing at sites of sustained pressure is not asked. The treatment with only antihistamines is not sufficient and requires additional therapy of oral steroids, non-steroidal anti-inflammatory drugs, colchicine, dapsone, sulfasalazine, intravenous immunoglobulins or omalizumab.
"If a patient with delayed pressure urticaria is posted for surgery then he should be carefully padded on the operating table, and non-invasive blood pressure monitoring should be minimum or invasive blood pressure monitoring can be used," write the authors.
The case has been published in the BMJ Case Reports.
Carry Home Points-
Delayed pressure urticaria is usually seen in patients with a previous history of urticaria or angioedema, but the diagnosis may be missed if specific history regarding weals developing at sites of sustained pressure is not asked.
The treatment with only antihistamines is not sufficient and requires additional therapy of oral steroids, non-steroidal anti-inflammatory drugs, colchicine, dapsone, sulfasalazine, intravenous immunoglobulins or omalizumab.
If a patient with delayed pressure urticaria is posted for surgery then he should be carefully padded on the operating table, and non-invasive blood pressure monitoring should be minimum or invasive blood pressure monitoring can be used.
For further reference follow the link: 10.1136/bcr-2018-227267
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd